Cargando…

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club

OBJECTIVES: To review the clinical value of bone turnover markers (BTM), to initiate and/or monitor anti-resorptive treatment for osteoporosis compared with bone mineral density (BMD) and to evaluate suitable BTM and changes in BTM levels for significance of treatment efficiency. METHODOLOGY: Consen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergmann, P, Body, J-J, Boonen, S, Boutsen, Y, Devogelaer, J-P, Goemaere, S, Kaufman, J-M, Reginster, J-Y, Gangji, V
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Consensus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705815/ https://www.ncbi.nlm.nih.gov/pubmed/19125989 http://dx.doi.org/10.1111/j.1742-1241.2008.01911.x

Ejemplares similares

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
por: Body, J.-J., et al.
Publicado: (2010)

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club
por: Body, J.-J., et al.
Publicado: (2011)

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
por: Body, J.-J., et al.
Publicado: (2012)

Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club
por: Gielen, E., et al.
Publicado: (2017)

Loading and Skeletal Development and Maintenance
por: Bergmann, P., et al.
Publicado: (2010)

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
por: Rozenberg, Serge, et al.
Publicado: (2015)

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
por: Laurent, Michaël R., et al.
Publicado: (2022)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
por: Collette, J., et al.
Publicado: (2009)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Diagnosis and treatment of venous malformations in China: consensus document
por: Wang, Deming, et al.
Publicado: (2019)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)
por: Silva, Barbara C., et al.
Publicado: (2022)

Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)
por: Madeira, Miguel, et al.
Publicado: (2020)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO)
por: Halpern, Bruno, et al.
Publicado: (2022)

Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival
por: Fromigue, O, et al.
Publicado: (2003)

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011)

Impact of whole dairy matrix on musculoskeletal health and aging–current knowledge and research gaps
por: Geiker, N.R.W., et al.
Publicado: (2019)

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
por: Statham, Louise, et al.
Publicado: (2020)

Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement
por: Unnikrishnan, A G, et al.
Publicado: (2009)

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
por: Ghadri, Jelena-Rima, et al.
Publicado: (2018)

A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
por: Canonica, Giorgio Walter, et al.
Publicado: (2013)

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
por: Ghadri, Jelena-Rima, et al.
Publicado: (2018)

Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities
por: Zheng, Kai, et al.
Publicado: (2020)

A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
por: Grine, L., et al.
Publicado: (2020)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men
por: Pye, S. R., et al.
Publicado: (2016)

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
por: Lambert, Catherine, et al.
Publicado: (2018)

Guidance on reuse of cardio-vascular catheters and devices in India: A consensus document
por: Kapoor, Aditya, et al.
Publicado: (2017)

Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region
por: Chandran, M., et al.
Publicado: (2021)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
por: Body, J. J., et al.
Publicado: (1997)

Organization of Bone Sarcoma Care: A Cross‐Sectional European Study
por: Goedhart, Louren Matthias, et al.
Publicado: (2020)

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2018)

Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management
por: Prato, S Del, et al.
Publicado: (2010)

Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oid9t68hjbdcd2k6ehb7olknej